Search results
Results From The WOW.Com Content Network
The GI cocktail is a mixture of a viscous anesthetic, an antacid, and an anticholinergic. [1] [2] Common viscous anesthetics use are viscous lidocaine or xylocaine.Common antacids used are magnesium hydroxide, aluminum hydroxide, or simethicone (more commonly known as Mylanta or Maalox). [3]
The pink lady is the de facto term describing xylocaine viscous and a liquid antacid given by mouth to treat emergency department patients and help determine if the chest pains are either heart or digestive related. If esophageal symptoms subside the treatment may indicate the symptoms are non-cardiac.
Several liquid antacid preparations are marketed. Common liquid preparations include milk of magnesia and magnesium/aluminum combinations. A potential advantage of using a liquid preparation over a tablet is that liquids may provide quicker relief, however this may coincide with a shorter duration of action. [19]
Eno was first marketed by James Crossley Eno (1827–1915). [4] Legend has it that his idea for the product arose while he was working at the pharmacy of an infirmary in Newcastle, Britain, with Dennis Embleton; Embleton often prescribed an effervescent drink made by mixing sodium bicarbonate and citric acid in water, and Eno adopted this beverage. [5]
Hyoscine butylbromide, also known as scopolamine butylbromide [4] and sold under the brandname Buscopan among others, [5] is an anticholinergic medication used to treat abdominal pain, esophageal spasms, bladder spasms, biliary colic, [6] and renal colic.
Liquid bandages are suitable for clean cuts that close easily and shallow small wounds, as it will help both sides of the wound to bond and produce a suture-like effect. Due to the drying of liquid wound dressing, it will form a nonelastic film on the wound and cannot absorb tissue fluid. If the wound area is too large, it will actually hinder ...
Based on a review of this drug by the National Academy of Sciences–National Research Council and/or other information, FDA has classified the indications as follows: "possibly" effective: For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
See also {{R to section}} and use together with this rcat when appropriate. If the topic of the redirect is not susceptible to expansion, then use other rcats such as {{R to section}} or {{R to list entry}} when appropriate. Since a new page may be created, links to this redirect should not be replaced with a direct link to the target page.